Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NMS-P715 is a highly selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 16,500 | |||
2 mg | 在庫あり | ¥ 22,500 | |||
5 mg | 在庫あり | ¥ 35,500 | |||
10 mg | 在庫あり | ¥ 57,000 | |||
25 mg | 在庫あり | ¥ 111,500 | |||
50 mg | 在庫あり | ¥ 164,500 | |||
100 mg | 在庫あり | ¥ 226,500 |
説明 | NMS-P715 is a highly selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM). |
ターゲット&IC50 | MELK:6.01 μM, CK2:5.7 μM, Mps1:182 nM, NEK6:6.02 μM |
In vitro | NMS-P715 (1 μM) inhibits the proliferation of HCT116 cells. And it causes mitotic acceleration in U2OS cells overexpressing YFP-α-tubulin, induces aneuploidy. NMS-P715 (0.5, 1 μM) affects mitotic checkpoint complex (MCC) stability and cdc20 ubiquitylation[1]. |
In vivo | NMS-P715 (90 mg/kg, p.o.) is well tolerated and causes no signs of body weight loss or other overt toxicities in an A2780 ovary carcinoma xenograft model[1]. |
分子量 | 676.73 |
分子式 | C35H39F3N8O3 |
CAS No. | 1202055-32-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2 mg/mL (2.96 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NMS-P715 1202055-32-0 Cytoskeletal Signaling MAPK Metabolism PI3K/Akt/mTOR signaling Stem Cells MELK Casein Kinase Kinesin NMS-P 715 Monopolar spindle 1 Mps1 NMS P715 NMS-P-715 inhibit NMSP715 Inhibitor inhibitor